FierceBiotech 2026年3月27日 AstraZeneca delivers dream result as phase 3 COPD hits breathe life into class rocked by flops
FierceBiotech 2026年3月26日 Pulmatrix picked for reverse merger with anti-aging biotech weeks after Cullgen deal collapses
FierceBiotech 2026年3月26日 Innate ends work on NK cell engager in phase 1/2 trial as part of ongoing pipeline refocus
FierceBiotech 2026年3月26日 Biopharma funding dropped 20% in 2025 as companies doubled down on big bets: IQVIA
FierceBiotech 2026年3月25日 FDA approves Denali's Hunter syndrome drug, handing rare disease community a win
FierceBiotech 2026年3月25日 Merck, girding for Keytruda cliff, flies toward promising CML asset with $6.7B Terns acquisition
FierceBiotech 2026年3月25日 After ph. 2 readout, analysts herald 'best-in-class potential' for Maze kidney candidate as stock plummets
FierceBiotech 2026年3月25日 BrightGene's oral dual agonist sees up to 8% weight loss at 8 weeks in slice of early data
FierceBiotech 2026年3月25日 Novo Nordisk prepares to go global as triple-G prospect passes midphase diabetes test in China